— Know what they know.
Not Investment Advice
Also trades as: 6618.HK (HKSE) · $vol 44M · JDHIF (OTC) · $vol 0M

JDHIY OTC

JD Health International Inc.
1W: -9.1% 1M: -9.1% 3M: -1.3% YTD: -49.5% 1Y: -49.5% 3Y: -25.1%
$4.59
-0.47 (-9.29%)
 
Weekly Expected Move ±4.7%
$4 $4 $5 $5 $5
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Sell · Power 52 · $14.7B mcap · 1.01B float · 0.0000% daily turnover · Short 100% of daily vol

Cash Flow Trends

Operating Cash Flow
$9.9B +129.0% ▲
5Y CAGR: +21.8%
Capital Expenditures
$9.9B -21304.6% ▼
5Y CAGR: +203.1%
Free Cash Flow
$0 -100.0% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$10.1B +33.1% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$1.1B$383M$2.1B$4.2B$5.2B
Depreciation & Amort.$63M$141M$227M$215M$272M
Stock-Based Comp.$2.6B$2.1B$1.8B$1.1B$0
Change in Working Capital$2.0B$2.8B$214M$525M$3.5B
Other Non-Cash Items-$496M-$845M$173M-$1.7B$919M
Operating Cash Flow$3.4B$5.9B$4.6B$4.3B$9.9B
— Investing Activities —
Capital Expenditures-$518M-$2.3B-$69M-$46M$0
Acquisitions (Net)-$8M-$3M$0-$825K$0
Investment Purchases-$46.3B-$33.1B-$47.6B-$38.3B-$36.7B
Investment Sales$29.1B$31.1B$39.7B$41.5B$36.2B
Other Investing$21M-$5M$18M-$17M-$88M
Investing Cash Flow-$17.8B-$4.2B-$8.0B$3.1B-$575M
— Financing Activities —
Net Debt Issuance-$32M$0-$34M-$37M$0
Stock Repurchased-$56M-$869M-$69M$0$0
Dividends Paid$0$0$0$0$0
Other Financing-$75M-$56M-$14M-$8M-$77M
Financing Cash Flow-$164M-$925M-$117M-$46M-$77M
Net Change in Cash-$15.0B$1.5B-$3.7B$7.6B$10.1B
Cash End of Period$17.3B$18.7B$15.0B$22.6B$31.8B
Free Cash Flow$2.9B$3.6B$4.5B$4.3B$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms